Envisioning a Transformed Clinical Trials Enterprise For 2030

by National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Carolyn Shore